Intracellular Expression of MICA in Activated CD4 T Lymphocytes and Protection from NK Cell-Mediated MICA-Dependent Cytotoxicity

Human Immunology

Volumn 67, Issue 3, 2006, Pages 170-182

  Molinero, Luciana Lorena ^a   Domaica, Carolina Inés ^a   Fuertes, Mercedes Beatriz ^a   Girart, María Victoria ^a   Rossi, Lucas Ezequiel ^a   Zwirner, Norberto Walter ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

MHC; MICA; NK cells; T lymphocytes

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; IONOMYCIN; JANUS KINASE 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 CHAIN RELATED A PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE FYN; PROTEIN KINASE LCK; S6 KINASE; STAT5 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL PROTECTION; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE CULTURE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TUMOR; VIRUS INFECTION; WESTERN BLOTTING;

CD4-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IONOMYCIN; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICROSCOPY, CONFOCAL; PROTEIN KINASES; TETRADECANOYLPHORBOL ACETATE; TH1 CELLS; TH2 CELLS;

EID: 33646480297     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.02.010     Document Type: Article

References (32)

1. Bahram S., Bresnahan M., Geraghty D.E., and Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci USA 91 (1994) 6259
2. Groh V., Bahram S., Bauer S., Herman A., Beauchamp M., and Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 93 (1996) 12445
3. Zwirner N.W., Fernández-Viña M.A., and Stastny P. MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells and monocytes. Immunogenetics 47 (1998) 139
4. Molinero L.L., Marcos C.Y., Mirbaha F., Fainboim L., Stastny P., and Zwirner N.W. Codominant expression of the polymorphic MICA alloantigens encoded by genes in the HLA region. Eur J Immunogenet 29 (2002) 315-319
5. Groh V., Steinle A., Bauer S., and Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 279 (1998) 1737-1740
6. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., and Spies T. Co-stimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2 (2001) 255-260
7. Das H., Groh V., Kuijl C., Sugita M., Morita C., Spies T., and Bukowski J.F. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity 15 (2001) 83-93
8. Groh V., Rhinehart R., Secrist H., Bauer S., Grabstein K.H., and Spies T. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB. Proc Natl Acad Sci USA 96 (1999) 6879-6884
9. Seliger B., Abken H., and Ferrone S. HLA-G and MIC expression in tumors and their role in anti-tumor immunity. Trends Immunol 24 (2003) 82-87
10. Pende D., Rivera P., Marcenaro S., Chang C.C., Biassoni R., Conte R., Kubin M., Cosman D., Ferrone S., Moretta L., and Moretta A. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes. analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 62 (2002) 6178-6186
11. Menier C., Riteau B., Carosella E.D., and Rouas-Freiss N. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal. Int J Cancer 100 (2002) 63-70
12. Pende D., Cantoni C., Rivera P., Vitale M., Castriconi R., Marcenaro S., Nanni M., Biassoni R., Bottino C., Moretta A., and Moretta L. Role of NKG2D in tumor cell lysis mediated by human NK cells. cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol 31 (2001) 1076-1086
13. Zwirner N.W., Dole K., and Stastny P. Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes. Hum Immunol 60 (1999) 323-330
14. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L., and Spies T. Activation of NK and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 (1999) 727-729
15. Wu J., Song Y., Bakker A.B.H., Bauer S., Spies T., Lanier L., and Phillips J.H. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285 (1999) 730-732
16. Bahram S., Inoko H., Shiina T., and Radosavljevic M. MIC and other NKG2D ligands. from none to too many. Curr Opin Immunol 17 (2005) 505-509
17. Bacon L., Eagle R.A., Meyer M., Easom N., Young N.T., and Trowsdale J. Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J Immunol 173 (2004) 1078-1084
18. Vivier E., Tomasello E., and Paul P. Lymphocyte activation via NKG2D. towards a new paradigm in immune recognition?. Curr Opin Immunol 14 (2002) 306-311
19. Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., Kubin M., and Chalupny N.J. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14 (2001) 123-133
20. Molinero L.L., Fuertes M.B., Rabinovich G.A., Fainboim L., and Zwirner N.W. Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28. J Leukoc Biol 71 (2002) 791-797
21. Molinero L.L., Fuertes M.B., Fainboim L., Rabinovich G.A., and Zwirner N.W. Up-regulated expression of MICA on activated T lymphocytes involves Lck and Fyn kinases, and signaling through MEK1/ERK, p38 MAP kinase and calcineurin. J Leukoc Biol 73 (2003) 815-822
22. Rothenberg E.V., and Ward S.B. A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation. Proc Natl Acad Sci USA 93 (1996) 9358-9365
23. Kuo C.T., and Leiden J.M. Transcriptional regulation of T lymphocyte development and function. Annu Rev Immunol 17 (1999) 149-187
24. Ballard D.W. Molecular mechanisms in lymphocyte activation and growth. Immunol Res 23 (2001) 157-166
25. Molinero L.L., Fuertes M.B., Girart M.V., Fainboim L., Rabinovich G.A., Costas M.A., and Zwirner N.W. NF-κB-regulates expression of the MHC class I related chain A gene (MICA) in activated T lymphocytes. J Immunol 173 (2004) 5583-5590
26. + T cells via OX40-OX40 ligand interactions. J Immunol 173 (2004) 3716-3724
27. + T cells. J Immunol 174 (2005) 4480-4484
28. Zwirner N.W., Marcos C.Y., Mirbaha F., Zou Y., and Stastny P. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol 61 (2000) 917-924
29. Goldbaum F.A., Leoni J., Wallace J.C., and Fossati C.A. Characterization of an 18-kilodalton Brucella cytoplasmatic protein which appears to be a serological marker of active infection of both human and bovine brucellosis. J Clin Microbiol 31 (1993) 2141-2145
30. Hue S., Mention J.J., Monteiro R.C., Zhang S., Cellier C., Schmitz J., Verkarre V., Fodil N., Bahram S., Cerf-Bensussan N., and Caillat-Zucman S. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21 (2004) 367-377
31. Rabinovich B.A., Li J., Shannon J., Hurren R., Chalupny J., Cosman D., and Miller R.G. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J Immunol 170 (2003) 3572-3576
32. Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity 15 (2001) 363-374